Common Shares Outstanding: The number of class A shares currently held by investors.
Aligos Therapeutics, Inc. (ALGS) had Common Shares Outstanding of 6.25M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
$2.87M |
|
$-21.86M |
|
-- |
|
$2.87M |
|
$24.76M |
|
$-21.89M |
|
$0.36M |
|
$-21.53M |
|
$-21.53M |
|
$-21.86M |
|
$-21.86M |
|
$-21.86M |
|
$-21.86M |
|
$-21.89M |
|
$-21.64M |
|
10.46M |
|
10.46M |
|
$-2.09 |
|
$-2.09 |
|
| Balance Sheet Financials | |
$34.68M |
|
$1.21M |
|
$12.51M |
|
$47.19M |
|
$19.60M |
|
-- |
|
$16.28M |
|
$35.88M |
|
$11.31M |
|
$11.31M |
|
$11.31M |
|
|
Common Shares Outstanding |
6.25M |
| Cash Flow Statement Financials | |
$-46.63M |
|
$59.80M |
|
$0.15M |
|
$18.41M |
|
$31.74M |
|
$13.33M |
|
$3.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.77 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
100.00% |
|
-762.98% |
|
-762.98% |
|
-- |
|
-750.58% |
|
-761.94% |
|
$-46.82M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-193.35% |
|
-193.35% |
|
-46.32% |
|
-193.35% |
|
$1.81 |
|
$-4.48 |
|
$-4.46 |
|